WST
NYSEWEST PHARMACEUTICAL SERVICES INC
Health Care, Health Care Supplies
$354.07
close 7 Aug 2026
+47.33%
52-week change
$24.93B
market cap
$223.83
$386.00
52-week range
Valuation
Market cap$24.93B
P/E (TTM / 5y avg)45.34x42.74x
Forward P/E (FY2026 / FY2027)39.52x35.53x
PEG (TTM / fwd)—3.52
P/S (TTM)7.49x
P/B8.34x
EV/EBITDA (TTM)28.65x
FCF yield (TTM)1.75%
Cash flow & dividend
FCF (TTM)$436.90M
FCF per share (TTM)$6.21
FCF margin (TTM)13.13%
Dividend yield (indicated / 5y avg)0.25%0.26%
Annualized dividend$0.8800
Payout ratio (EPS / FCF)11.05%14.28%
Growth & quality
Revenue YoY, latest Q+13.80%
Diluted EPS YoY, latest Q+18.13%
Operating margin (TTM)20.45%
Net margin (TTM)16.98%
ROE (latest FY)15.54%
Net debt / EBITDA (TTM)-0.27
Interest coverage (TTM)35.62
Price
-18.47%-4.02%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +7.44%10Y CAGR +8.18%
Diluted EPS
5Y CAGR +8.24%10Y CAGR +17.98%
FCF per share
5Y CAGR +10.38%10Y CAGR +19.36%
Operating cash flow
5Y CAGR +9.82%10Y CAGR +13.52%
Free cash flow
5Y CAGR +9.48%10Y CAGR +19.22%
Dividends per share
5Y CAGR +5.80%10Y CAGR +6.69%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -0.55%10Y CAGR -0.04%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date21 Oct 2026bmo
EPS estimate$2.20
Revenue estimate$832.54M
Last reported
Date—
EPS——
Revenue——